Ruan Z - Search Results

1

Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review.

Zou H, Ge Y, Lei Q, Ung COL, Ruan Z, Lai Y, Yao D, Hu H. Zou H, et al. Among authors: ruan z. Hepatol Int. 2022 Feb;16(1):27-37. doi: 10.1007/s12072-021-10286-4. Epub 2022 Jan 31. Hepatol Int. 2022. PMID: 35098442

2

The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review.

Ruan Z, Yang L, Shi H, Yue X, Wang Y, Liang M, Hu H. Ruan Z, et al. Expert Rev Pharmacoecon Outcomes Res. 2021 Apr;21(2):221-233. doi: 10.1080/14737167.2021.1860022. Epub 2021 Jan 12. Expert Rev Pharmacoecon Outcomes Res. 2021. PMID: 33317348

3

Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review.

Luo Z, Ruan Z, Yao D, Ung COL, Lai Y, Hu H. Luo Z, et al. Among authors: ruan z. Front Public Health. 2021 Nov 19;9:765999. doi: 10.3389/fpubh.2021.765999. eCollection 2021. Front Public Health. 2021. PMID: 34869180 Free PMC article.

4

Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review.

Ruan Z, Zou H, Lei Q, Ung COL, Shi H, Hu H. Ruan Z, et al. Expert Rev Pharmacoecon Outcomes Res. 2022 Jun;22(4):555-574. doi: 10.1080/14737167.2022.2042255. Epub 2022 Feb 18. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35152812

5

Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China.

Ruan Z, Ung COL, Shen Y, Zhang Y, Wang W, Luo J, Zou H, Xue Y, Wang Y, Hu H, Guo L. Ruan Z, et al. Diabetes Ther. 2022 Oct;13(10):1737-1753. doi: 10.1007/s13300-022-01301-4. Epub 2022 Aug 8. Diabetes Ther. 2022. PMID: 35934763 Free PMC article.

6

Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials.

Lin Q, Xue Y, Zou H, Ruan Z, Ung COL, Hu H. Lin Q, et al. Among authors: ruan z. Expert Rev Clin Pharmacol. 2022 Dec;15(12):1461-1469. doi: 10.1080/17512433.2022.2130760. Epub 2022 Oct 5. Expert Rev Clin Pharmacol. 2022. PMID: 36180402

7

Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China.

Liu L, Ruan Z, Ung COL, Zhang Y, Shen Y, Han S, Jia R, Qiao J, Hu H, Guo L. Liu L, et al. Among authors: ruan z. Diabetes Ther. 2023 Jan;14(1):93-107. doi: 10.1007/s13300-022-01336-7. Epub 2022 Nov 22. Diabetes Ther. 2023. PMID: 36414806 Free PMC article.

8

Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review.

Ruan Z, Jiang Y, Shi H, Jia R, Ung COL, Hu H. Ruan Z, et al. Expert Rev Clin Pharmacol. 2023 Feb;16(2):161-176. doi: 10.1080/17512433.2023.2174099. Epub 2023 Feb 2. Expert Rev Clin Pharmacol. 2023. PMID: 36706368

9

Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research.

Xue Y, Ruan Z, Ung COL, Lai Y, Hu H. Xue Y, et al. Among authors: ruan z. BMC Public Health. 2023 Jun 21;23(1):1198. doi: 10.1186/s12889-023-15890-7. BMC Public Health. 2023. PMID: 37344819 Free PMC article.

10

Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature.

Xue Y, Zou H, Ruan Z, Chen X, Lai Y, Yao D, Ung COL, Hu H. Xue Y, et al. Among authors: ruan z. Front Endocrinol (Lausanne). 2023 Nov 6;14:1254398. doi: 10.3389/fendo.2023.1254398. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027186 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,643 results

Search Page

Filters